Primary Site >> Liver Cancer
Gene >> NCAM1
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: [Immunological effects of locoregional immunochemotherapy for liver metastases of gastric cancer]. PMID: 8373205 |
Ref: Two-step targeting and dosimetry for small cell lung cancer xenograft with anti-NCAM/antihistamine bispecific antibody and radioiodinated bivalent hapten. PMID: 10405144 |
Ref: A nude mice model of human rhabdomyosarcoma lung metastases for evaluating the role of polysialic acids in the metastatic process. PMID: 11314035 |
Ref: Intrahepatic clear cell cholangiocarcinoma: immunohistochemical aspects in a very rare type of cholangiocarcinoma. PMID: 17527078 |
Ref: N-cadherin serves as diagnostic biomarker in intrahepatic and perihilar cholangiocarcinomas. PMID: 18622386 |
Ref: Expression of contactin associated protein-like 2 in a subset of hepatic progenitor cell compartment identified by gene expression profiling in hepatitis B virus-positive cirrhosis. PMID: 19889080 Ref: The properties of tumor-initiating cells from a hepatocellular carcinoma patient's primary and recurrent tumor. PMID: 19897602 |
Ref: Clinicopathologic study on combined hepatocellular carcinoma and cholangiocarcinoma: with emphasis on the intermediate cell morphology. PMID: 21860552 |
Ref: alpha-Fetoprotein-producing gastric carcinoma and combined hepatocellular and cholangiocarcinoma show similar morphology but different histogenesis with respect to SALL4 expression. PMID: 22516245 Ref: Transcriptomic profiling reveals hepatic stem-like gene signatures and interplay of miR-200c and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma. PMID: 22707408 |
Ref: Hypervascular hepatocellular carcinomas showing hyperintensity on hepatobiliary phase of gadoxetic acid-enhanced magnetic resonance imaging: a possible subtype with mature hepatocyte nature. PMID: 23771695 Ref: Clinicopathologic significance of combined hepatocellular-cholangiocarcinoma with stem cell subtype components with reference to the expression of putative stem cell markers. PMID: 23955451 |
Ref: Identification of typical miRNAs and target genes in hepatocellular carcinoma by DNA microarray technique. PMID: 24452951 |
Ref: [Combined hepatocellular-cholangiocarcinoma (cholangiolocellular type) with stem-cell features: a clinicopathologic analysis of 26 cases]. PMID: 26956962 Ref: De novo HAPLN1 expression hallmarks Wnt-induced stem cell and fibrogenic networks leading to aggressive human hepatocellular carcinomas. PMID: 27191501 Ref: Identification of hub genes and pathways associated with hepatocellular carcinoma based on network strategy. PMID: 27703495 Ref: A Transcriptomic Signature of Mouse Liver Progenitor Cells. PMID: 27777588 |
Ref: Analysis of differentially co-expressed genes based on microarray data of hepatocellular carcinoma. PMID: 28043148 Ref: Mixed hepatocellular cholangiocarcinoma tumors: Cholangiolocellular carcinoma is a distinct molecular entity. PMID: 28126467 Ref: Tumour epithelial and stromal characteristics of hepatocellular carcinomas with abundant fibrous stroma: fibrolamellar versus scirrhous hepatocellular carcinoma. PMID: 28326574 Ref: Liver cancers with stem/progenitor-cell features - a rare chemotherapy-sensitive malignancy. PMID: 28938700 |
Ref: Clinical outcome of hepatocellular carcinoma can be predicted by the expression of hepatic progenitor cell markers and serum tumour markers. PMID: 29774107 Ref: Neuroendocrine tumor of the pancreas with rhabdoid feature. PMID: 29938394 Ref: Pathologic differential diagnosis of metastatic carcinoma in the liver. PMID: 30300991 |